Tag: Idecabtagene vicleucel

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Idecabtagene vicleucel

2seventy stock hits new 52-week low on Abecma sales report (NASDAQ:TSVT)

Added to Collection on: 2023-10-26 21:18:42

Tags for this article:

Bristol-Myers Squibb
Gene therapy
Idecabtagene vicleucel
Bluebird bio
Multiple myeloma
Bristol Myers

Click the tags to see associated articles and topics

View Article Details
Bristol Myers faces FDA delay on cancer cell therapy decision | BioPharma Dive

Added to Collection on: 2023-11-20 17:22:44

Tags for this article:

Gene therapy
Bristol-Myers Squibb
Breakthrough therapy
Orphan drugs
Idecabtagene vicleucel
Multiple myeloma
CAR T cell

Click the tags to see associated articles and topics

View Article Details
US FDA seeks 'boxed warning' for CAR-T cancer therapies | Health - Devdiscourse

Added to Collection on: 2024-01-23 17:22:45

Tags for this article:

CAR T-cell therapy
Orphan drugs
Cancer treatments
Immune system
T cells
CAR T cell
Tisagenlecleucel
Brexucabtagene autoleucel
Bristol-Myers Squibb
Novartis
Idecabtagene vicleucel
Gilead Sciences

Click the tags to see associated articles and topics

View Article Details
US FDA seeks 'boxed warning' for CAR-T cancer therapies - AOL.com

Added to Collection on: 2024-01-23 17:21:59

Tags for this article:

CAR T-cell therapy
Orphan drugs
Cancer treatments
Immune system
T cells
CAR T cell
Tisagenlecleucel
Brexucabtagene autoleucel
Bristol-Myers Squibb
Idecabtagene vicleucel
Gilead Sciences
Novartis
Novartis AG

Click the tags to see associated articles and topics

View Article Details
Regeneron to acquire 2seventy's cell therapy pipeline - Yahoo Finance

Added to Collection on: 2024-01-30 19:59:09

Tags for this article:

Regeneron Pharmaceuticals
Bluebird bio
George Yancopoulos
Idecabtagene vicleucel
Bristol-Myers Squibb
Multiple myeloma
Sanofi

Click the tags to see associated articles and topics

View Article Details
Patient-Centric Care in R/R MM - Cancer Network

Added to Collection on: 2024-02-01 21:43:26

Tags for this article:

Orphan drugs
Multiple myeloma
Daratumumab/hyaluronidase
Daratumumab
Teclistamab
Talquetamab
Idecabtagene vicleucel
Genmab
Isatuximab

Click the tags to see associated articles and topics

View Article Details
J&J secures EMA backing for earlier CAR-T use in multiple myeloma - BioPharma Dive

Added to Collection on: 2024-02-23 17:07:20

Tags for this article:

Orphan drugs
CAR T-cell therapy
Antineoplastic drugs
Immunosuppressants
Idecabtagene vicleucel
Multiple myeloma
CAR T cell
Lenalidomide
Ciltacabtagene autoleucel
Cereblon E3 ligase modulator
Bristol-Myers Squibb
B-cell maturation antigen

Click the tags to see associated articles and topics

View Article Details
U.S. FDA Approves Bristol Myers Squibb and 2seventy bio'sAbecma for Triple-Class ...

Added to Collection on: 2024-04-06 13:28:46

Tags for this article:

Orphan drugs
Idecabtagene vicleucel
Multiple myeloma
Elotuzumab
Carfilzomib
Pomalidomide
Lenalidomide
CAR T cell
Daratumumab
Ixazomib
Bristol-Myers Squibb
2SEVENTY BIO, INC.
United States
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details